VEGFA and neoplasm: However, while targeting VEGF to inhibit MDSC recruitment seems an interesting therapeutic option, it may also trigger, in parallel, tumor hypoxia and GM-CSF expression, which will sustain MDSC recruitment in ovarian tumors [122].